BVS Q2 2020 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$581M

Q2 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$58M-27.6% YoY

Gross Profit

$40M69.5% margin

Operating Income

-$5M-7.9% margin

Net Income

-$6M-9.9% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

-26.2%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$7M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$509M

Total Liabilities

$368M

Stockholders' Equity

$139M

Cash & Equivalents

$126M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$58M	$80M	-27.6%
Gross Profit	$40M	$58M	-30.0%
Operating Income	-$5M	$3M	-233.2%
Net Income	-$6M	-$3M	-100.7%